Celgene (CELG) Makes Big Push Into Solid Tumor Space With $2.9 Billion Acquisition of Abraxis (ABII)
Tweet Send to a Friend
Biotechnology company Celgene Corp. (NASDAQ: CELG) said Wednesday that it has agreed to buy Abraxis BioScience Inc. (NASDAQ: ABII) for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
